Latest News

Moderna (MRNA) opened 2026 with Q1 results that continue the recent trend of revenue and losses sitting side by side, with trailing 12 month revenue at US$1.9 billion and a basic EPS loss of US$7.25 per share tied to a net loss of US$2.8 billion. Over recent quarters, the company has seen quarterly revenue move between US$108 million and US$1.9 billion with basic EPS ranging from a small profit of US$0.03 per share in Q3 2024 to losses of more than US$2.50 per share in several 2025 quarters,...

Vanguard Capital Management has disclosed a 7.3% stake in Cencora (NYSE:COR) via a Schedule 13G filing. The filing identifies Vanguard as one of Cencora’s largest institutional holders and classifies the position as being held for investment purposes. Cencora operates as a major player in pharmaceutical distribution and related healthcare services, sitting at the center of drug supply chains that connect manufacturers, pharmacies, and providers. With its scale and logistics capabilities,...

If you are wondering whether Snap at around US$6.29 is a bargain or a value trap, the key is understanding what the current price actually reflects about its future. The share price has moved sharply in the short term, with returns of 11.3% over the last 7 days and 35.9% over the last 30 days, set against a year to date return of negative 22.6% and a 1 year return of negative 25.6%. These moves come as Snap continues to sit in the spotlight of investors who are weighing its long term...

With inflation pressures, tighter central bank policy and mixed growth signals across major economies, many investors are looking for companies that can keep compounding value without depending on easy money or booming demand. A focus on high return on equity, solid past performance and strong balance sheets can help concentrate on businesses that have already shown they can turn every dollar of capital into meaningful profits while keeping debt in check. This article highlights 3 stocks from...

Piper Sandler Companies (PIPR) has entered Q1 2026 with trailing 12 month revenue of about US$1.9b and basic EPS of US$4.22. This is alongside year over year earnings growth of 55.3% and revenue growth of 9.8%. Over the past reported quarters, total revenue has moved from US$484.1 million in Q4 2024 to US$666.1 million in Q4 2025, while quarterly basic EPS has ranged from US$0.55 in Q3 2024 to US$1.69 in Q4 2025. Taken together, these figures present a picture of improving profitability and...

Why Kemira Oyj (HLSE:KEMIRA) is back on investors’ radar Kemira Oyj (HLSE:KEMIRA) has drawn fresh attention after first quarter 2026 results showed lower sales and net income than a year earlier, alongside new full year 2026 revenue guidance. See our latest analysis for Kemira Oyj. The 1-day share price return of 3.0% to €17.65 comes after a weaker first quarter and a new 2026 revenue range, while a 30-day share price decline of 8.6% contrasts with a 5-year total shareholder return of 56.7%...

Some investors rely on dividends for growing their wealth, and if you're one of those dividend sleuths, you might be...

CT Vision (International) Holdings Limited ( HKG:994 ) insiders who bought shares over the past year were rewarded...

It's been a mediocre week for CUC Inc. ( TSE:9158 ) shareholders, with the stock dropping 18% to JP¥776 in the week...

It's been a pretty great week for Kandenko Co.,Ltd. ( TSE:1942 ) shareholders, with its shares surging 11% to JP¥6,734...

It's been a pretty great week for NGK Corporation ( TSE:5333 ) shareholders, with its shares surging 16% to JP¥5,121 in...

Sumitomo (TSE:8053) has laid out its FY 2026 scorecard with third quarter revenue of about ¥1.8 trillion and basic EPS of ¥89.49, set against a trailing twelve month revenue base of roughly ¥7.4 trillion and EPS of ¥458.92 that highlight how much earnings power it has put together over the past year. The company has seen quarterly revenue range from around ¥1.75 trillion to ¥1.98 trillion since FY 2025 Q2, while EPS has moved between ¥89.49 and ¥141.26, giving investors a clear view of how...

Tyler Technologies (NYSE:TYL) has completed its third largest acquisition, For The Record, adding court recording and transcription technology to its portfolio. The company has updated revenue guidance to reflect FTR and is leaning on the deal to support its shift toward cloud and AI-enabled solutions. Tyler is advancing its cloud migration plan, targeting nearly all new public safety clients and 80% of on premise customers to be in the cloud by 2030. For Tyler Technologies, a long time...

If you are wondering whether Dorman Products is attractively priced or looking stretched at around US$112.88, this article walks through the numbers that matter for valuation. The stock price sits at US$112.88, with returns of 1.5% over the last week, 11.9% over the last month, a 9.0% decline year to date, and a 2.1% decline over the last year. These returns are set against 27.7% and 8.1% over the past 3 and 5 years. Recent news coverage has focused on Dorman Products in the context of...

Dividend announcement in the spotlight of legal scrutiny Hercules Capital (HTGC) has drawn fresh attention after multiple law firms launched securities class action lawsuits, alleging misstatements around deal sourcing, loan origination, and portfolio valuation processes. These cases follow reports questioning whether Hercules Capital overstated its due diligence and misclassified certain investments, putting the accuracy of past public disclosures and reported asset values under closer...

If you are wondering whether American Tower is priced attractively or asking too much for its prospects, you are in the right place for a clear look at what the current share price might actually reflect. The stock last closed at US$181.61, with returns of 1.9% over the past week, 4.5% over the last month, 3.9% year to date, but a 15.8% decline over the past year and a 14.6% decline over five years. Recent coverage has focused on how American Tower fits into telecom and infrastructure...

Asahi Kasei (TSE:3407) has drawn fresh attention after starting a Phase I clinical trial for AK1940, a peptide-based autoimmune drug candidate that management links to its medium-term pharmaceutical growth plans. See our latest analysis for Asahi Kasei. The AK1940 trial and recent bond shelf registration activity come as Asahi Kasei’s share price trades at ¥1,524.5, with a 1-year total shareholder return of 55.53% and 3-year total shareholder return of 75.92%. This suggests momentum has been...

Why Liontown's latest quarter matters for investors Liontown (ASX:LTR) just reported its strongest quarter since production began, with first time positive net cash flow linked to spodumene sales and an underground shift at Kathleen Valley, plus fresh expansion spending commitments. See our latest analysis for Liontown. The recent quarterly update and expansion plans appear to be feeding into strong momentum, with a 30 day share price return of 55.75% and a year to date share price return of...

Investors in Tokyo Electron Limited ( TSE:8035 ) had a good week, as its shares rose 3.5% to close at JP¥47,450...

South Bow (TSX:SOBO) is drawing extra attention as investors look ahead to its May 7 earnings report, after previous quarters delivered sizeable earnings surprises and current indicators point to another potential beat versus expectations. See our latest analysis for South Bow. At a current share price of CA$47.23, South Bow’s recent momentum is firm, with a 1-day share price return of 1.57% and a 90-day share price return of 22.07%. The 1-year total shareholder return of 43.74% points to...

AEON REIT Investment (TSE:3292) has scheduled a board meeting for April 30, 2026, to approve a planned leadership reshuffle at its asset manager, including the appointment of veteran executive Muneaki Yamamoto as director. See our latest analysis for AEON REIT Investment. At a share price of ¥125,400, AEON REIT Investment has seen a 1 day share price return close to flat. Its year to date share price return of a 9% decline contrasts with a 1 year total shareholder return of 3.52%, suggesting...

This article examines whether Paramount Skydance at around US$11.09 is a bargain or a value trap, and what the current price could be indicating about the stock. The share price has moved 1.1% over the last week and 19.9% over the last month, yet year to date it sits at a 15.9% decline and the 5 year return is a 68.3% decline, which can influence how investors think about both risk and potential reward. Investors have been watching Paramount Skydance closely after recent coverage of the...

Why PLS Group’s new debt deal matters for shareholders PLS Group (ASX:PLS) has closed a US$600 million 6.875% Senior Notes issue due 2031, refinancing its revolving credit facility and reshaping its debt profile to better match long term lithium operations. The company used part of the proceeds to repay the A$375 million drawn on its revolving credit facility, reducing the facility size from A$1,000 million to A$500 million. The remaining funds are earmarked for general corporate...

Otsuka Corporation ( TSE:4768 ) just released its first-quarter report and things are looking bullish. The company beat...